International Women’s Day: Women in Science and Food and Agriculture

In honor of today being International Women’s Day, and March representing National Women’s Month, I’d like to profile a few of the influential women working at the intersection of science and food and agriculture.

Allison Van Eenennaam

Allison Van Eenennaam is a specialist in animal genomics and biotechnology working in the Department of Animal Science at the University of California, Davis. She is a vocal proponent of using biotechnology in agricultural to drive innovation and frequently showcases her expertise and passion on the issue through education and public events. She was the recipient of the 2014 Borlaug CAST Communication Award and was prominently featured in the film Food Evolution. Allison is so adamant about raising public awareness around agriculture issues, such as research funding and consumer acceptance of technology, that her and her team of scientists have created some very entertaining videos to educate the public. Fast forward to 2:33 in her team’s Gene Shop video, a parody of Macklemore’s Thrift Shop, to see and hear Allison’s solo performance.

Emma Naluyima Mugerwa

Emma Naluyima Mugerwa is a smallholder farmer and private veterinarian from Uganda who has advised other local farmers, as well as Uganda’s President, on improving livestock through genetics. She may be best known for her role in the film Food Evolution, where she worked with scientists to educate African communities on the humanitarian benefits of biotechnology in agriculture, specifically gene modification. Emma’s approach to enhancing food using biotechnology boils down to the idea that “everyone needs to eat”.  During her formative years as a student, Emma was taught how to farm for both food and income by her teachers and grandmother. In honor of her work, Emma was asked to give the keynote address at the 2014 World Food Prize, where she discussed her work in Uganda and how we can continue to feed the growing world by leveraging biotechnology.

Mary-Dell Chilton

We profiled Mary-Dell Chilton in our 25th anniversary piece looking back at her work with  agrobacterium. The discovery of this natural method of gene modification has led to countless innovations in the field of agriculture, contributing to the 4.58 million acres of GM crops sustainably grown around the world today. In 2013, Chilton was honored with the World Food Prize for her groundbreaking work. Like Emma Naluyima Mugerwa, Chilton views the benefits of agricultural biotechnology through a humanitarian lens. In response to winning the Award, Chilton noted “With biotechnology, we are working with nature on a higher level to more precisely determine the outcome of crops. Through ongoing research, we can continually improve their quality and productivity and do this in a way that will allow future generations to provide for their needs as well.”

Nina Fedoroff 

A molecular biologist by training, Fedoroff has long been involved in regulatory issues surrounding genetic modification of organisms (GMOs), serving on countless scientific advisory bodies including the National Science Foundation and the National Academy of Sciences (NAS). Dr. Fedoroff was an author of a 1987 NAS Council White Paper which first articulated the principle that GMOs should be regulated based on their properties, not on the method by which they were derived. In 2007, President George W. Bush awarded her the National Medal of Science. She has contributed to education and public policy pertaining to recombinant DNA and genetic modification of plants.” She lectures all over the world and is a frequent media contributor on the history and science of genetically modified organisms, science diplomacy and the future of food production.

Tamar Haspel

While Tamar Haspel is not a scientist or researcher by trade, she is an influential figure in the food and agriculture space because of her extensive reporting on food and science for the Washington Post’s Unearthed blog. Her blog addresses many of the questions, and subsequently much of the confusion, around science and food. As a journalist she is careful to consider both sides of the debate when writing about biotechnology, or using GMOs, in food production. And, Tamar doesn’t stick to her day job. According to her website, when she’s not “knee-deep in the public food conversation” she gets “dirty” raising chickens and oysters, growing her own vegetables and trying “to stay connected to the idea that food has to come from somewhere.”

 

 

Should You Stay Away From Healthcare Stocks?

Click to view a price quote on ABT.

Value Fund LP Biotechnology Purchases 6333333 Shares of CTI BioPharma Corp (CTIC) Stock

CTI BioPharma logo CTI BioPharma Corp (NASDAQ:CTIC) insider Value Fund L. P. Biotechnology purchased 6,333,333 shares of the firm’s stock in a transaction dated Friday, February 9th. The stock was acquired at an average cost of $3.00 per share, for a total transaction of $18,999,999.00.

Local Government Bans GM Crops to Decrease Pesticide Use While County Continues to Use Pesticide

The use of fearmongering around genetically modified (GM) crops by the organic industry has led to ballot initiatives in several states and counties looking to ban the technology. Arguably, the most famous example was highlighted in Food Evolution when Hawaii outlawed GM crops only to reverse course and rely on the technology to save one of the state’s most popular exports, the papaya, from being wiped out by disease.

In a recent piece for the Daily Camera, Mara Abbott looks at a similar case currently taking place on the U.S. mainland in Boulder County, Colorado. Abbott writes about Boulder County’s Cropland Policy, which was passed in 2016 and bans the use of GM crops on county-owned open land. As a result, many farmers that lease land from the county are prohibited from growing GM crops.

Spearheaded by county commissioners Elise Jones and Deb Gardner, the underlying goal of the ban was to decrease the use of glyphosate, a pesticide that is commonly used on GM crops. As part of the ban, county officials were to conduct research on alternatives to GM crops to help farmers who leased county land and were now on the wrong side of the law. However, as Abbott points out, the county looked to uneven the playing field in their favor during the bidding process for the research project:

The original research project vision, the Sustainable Agriculture Research and Innovation Initiative – SARII – was scrapped last fall due to accusations of a fixed process in the first bid attempt and a lack of interest from viable tenants in the second.

Fast forward more than a year later and inaction by the county allowed field bindweed to start taking over the land that was to be researched. And, as a result:

Acting on a desire to reduce the use of pesticides, the county commissioners held a piece of land out of production for over a year, hoping to use it for a research project that failed before it even started, during which time enough weeds grew on the property that the county staff had to treat them with the very chemical Jones and Gardner wished to avoid.

Pretty ironic, right? But, what’s even more ironic? While glyphosate is continuing to be used by county officials, farmers looking to lease county land to grow GM crops – which have “allowed the local farmers to be more targeted and effective with pesticides, reducing [glyphosate] use compared to previously grown conventional crops by 80 percent” – are restricted from doing so.

As Abbott writes in closing:

The GMO ban overly simplified the challenges of a complex industry.

Read Mara Abbott’s full piece here.

iShares NASDAQ Biotechnology Index (NASDAQ:IBB) Holdings Increased by CLS Investments LLC

iShares NASDAQ Biotechnology Index logo CLS Investments LLC raised its stake in iShares NASDAQ Biotechnology Index (NASDAQ:IBB) by 343.7% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 55,581 shares …

iShares NASDAQ Biotechnology Index (NASDAQ:IBB) Holdings Raised by Verity Asset …

iShares NASDAQ Biotechnology Index logo Verity Asset Management Inc. increased its stake in iShares NASDAQ Biotechnology Index (NASDAQ:IBB) by 200.7% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 26,532 shares of the …

BIO at 25 – A View of the Past; a Glimpse into the Future

In recognition of BIO’s 25th anniversary, BIO CEO and President, Jim Greenwood sat down with two early champions to talk about what triggered the formation of the organization and what we can learn from the past to help shape the future. That future is envisioned by BIO’s current chair, Dr. John Maraganore in a third video.

First up is Fred Frank, the first life sciences specialist in investment banking. In a career spanning nearly 60 years, Frank served as the lead underwriter in more than 125 initial public offerings. He negotiated more than 75 mergers and acquisitions, including some of the largest and most important transactions in the history of biotechnology.

Next Greenwood looks back to 1993-the year BIO was established-with Robert Beckman, one of the founding members.  Beckman is currently a managing partner at The Channel Group which provides management consulting services to life sciences companies.

After talking about where BIO came from, Greenwood talked about where we are going with Dr. John Maragaore, BIO’s current chair and CEO of Alnylam Pharmaceuticals, Inc. Maraganore has led a career pursuing therapies to address unmet medical needs. At Alnylam Pharmaceuticals, Maraganore is helping lead the development of RNAi therapeutics which aim to address genetic medicines, cardio-metabolic diseases and hepatic infectious diseases.

Secretary Azar Talks Opioid Strategy with NGA

Recently, HHS Secretary Alex Azar joined the National Governors Association to discuss opioid addiction and abuse in America. While we can all agree that there is no silver bullet to solving this problem, Secretary Azar outlined several proposals – consistent with recommendations BIO recently released – that the public and private sectors can take to help prevent opioid use disorders in current and future generations.

Understand the Foundations of Pain and Addiction

“We have to understand this crisis in order to stop it,” Azar noted, which BIO has also identified as the first step in moving forward. Before we can develop novel, safer treatments, we must better understand the biology underlying pain and addiction. Government entities like the National Institutes of Health (NIH) can advance basic research which allow for health care professionals, as well as biopharmaceutical innovators, to better understand how to safely treat and manage pain and addiction.

Utilize Resources from the Public and Private Sectors

“We clearly need more tools to help us win this fight, which is why HHS supports cutting edge research on pain and addiction … The potential advances we’re seeing at NIH and in the private sector-like non-addictive painkillers and new methods of addiction treatment-are incredible,” Azar added.

It’s true: many promising, innovative treatments are under development that have the potential to transform the standard of care for pain and addiction. For example, scientists have created an injectable that treats knee pain using capsaicin, a by-product produced of chili peppers; and new therapies that target the body’s peripheral nervous system to treat pain without inducing addictive side effects are on the horizon.

Yet while the future is bright, we must do more. A new report from BIO shows that there isn’t the same level of investment committed to pain and addiction research as there are for other diseases that also inflict a heavy toll on patients and society. For example, the oncology pipeline currently has 2,671 total active clinical programs – that’s more than 10 times the number found in the pain pipeline (220).

That’s why we’ve recommended several policies that will stimulate research and development of innovative treatments that effectively treat pain and opioid addiction and prevent abuse, including modernizing drug development and review processes.

Break Barriers and Expand Access to Safer, Novel Treatments

“People in communities all across America-in our own cities and towns-are alive today because of the progress that has been made in making drugs like naloxone available when and where they’re needed. … [W]e’re committed to working with you to ensure communities have access to these lifesaving drugs,” Azar told the group.

He also noted that, “Medication-assisted treatment works. The evidence on this is voluminous and ever growing.” We couldn’t agree more.

Unfortunately, not all patients have access to the same medicines and cures. As we see time and time again, restrictive insurance coverage and reimbursement policies are often standing between patients and the  most appropriate pain and addiction treatment. As we’ve pointed out before, we must break the barriers that impede patients’ access to the most appropriate treatments – including medication assisted treatment – and stimulate the development of novel and safer therapies to manage this growing public health crisis.

At BIO, we are committed to developing innovative solutions that will allow for an America free of prescription opioid addiction. Learn about our efforts here and check out our refreshed Toolkit for Advocates to find the latest materials and resources on this important issue.

March Lawn & Garden To-Do List – Today’s Homeowner

Flowers blooming

March marks the arrival of spring, but depending on where you live, freezing weather can persist well past the official start of spring. Read more to find out how to get your lawn and garden ready for the upcoming growing season.

Tiger vs bear: Ferocious fight caught on camera at Indian national park

Tiger vs bear: Ferocious fight caught on camera at Indian national park
Video shot at the Tadoba National Park in the Indian state of Maharashtra on Wednesday, shows an adult tiger face off with the sloth bear.

For more info, please go to https://globalnews.ca/news/4060559/tiger-vs-bear-ferocious-fight-caught-on-camera-at-national-park-in-india/

Subscribe to Global News Channel HERE: http://bit.ly/20fcXDc
Like Global News on Facebook HERE: http://bit.ly/255GMJQ
Follow Global News on Twitter HERE: http://bit.ly/1Toz8mt
[Read More …]

1 28 29 30 31 32 46